Tag:

vaccines

Latest Headlines

Latest Headlines

Groups urge FTC to investigate vaccine 'bundling'

Several watchdog groups are calling upon the Federal Trade Commission to investigate Sanofi Pasteur and Merck for allegedly forcing doctors to buy bundled vaccines.

Pfizer and GSK boost pneumonia vaccine price cuts for developing world

Just in time for the holiday season, Pfizer ( $PFE ) and GlaxoSmithKline ( $GSK ) said they are selling an additional 360 million doses of their pneumonia vaccine to a global health organization at a

Gates-funded computer model tackles vaccine woes

Vaccines spoil quickly under certain conditions and leave people who are vulnerable to disease without jabs. Now computer models developed at the University of Pittsburgh could help planners avert...

Live From BIO: Vaccines in the 21st century

CHICAGO - With new pathogens coming to the fore, new vaccines are absolutely still necessary, an expert panel said Tuesday at the BIO 2010 convention. But while opportunities exist, so do a number of

Sanofi exec, Novartis pipeline snag vaccine awards

CHANTILLY, VA - This week saw attendees gather just outside Washington, D.C. for the 2010 World Vaccines Congress to discuss the latest in the vaccine world. Although some attendees couldn't attend

Merck hires ex-CDC chief to head vaccines unit

Julie Gerberding, who headed the CDC while President George W. Bush was in office, is joining Merck as president of its $5 billion vaccines division. Gerberding, who is replacing the retiring Margie

Cocaine addiction vax trial offers some hope to users

An experimental vaccine designed to combat cocaine addiction demonstrated some promising results in a small human trial. Scientists in Texas say that the vaccine triggers the production of antibodies

Regulators approve a new jab for dogs

The USDA has approved the first new vaccine to protect dogs from the H3N8 flu virus. The virus evidently first jumped from horses to dogs about five years ago and is particularly lethal for canines

Transplant drug offers surprising boost for vaccines

A drug used to block immune cells from attacking transplanted organs also triggers the increased production of memory T-cells, and that could play a surprising role in boosting the effectiveness of

Opko Health buys vax development platform

Opko Health has decided to move into vaccine development and diagnostics following a crucial clinical trial failure in opthalmology last March. Opko licensed a new platform technology from UT